Abbott (ABT) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
BofA/Merrill Lynch Upgrades Abbott Labs (ABT) to Buy
January 30, 2015 6:58 AM ESTBofA/Merrill Lynch upgraded Abbott Labs (NYSE: ABT) from Neutral to Buy with a price target of $52.00 (from $50.00).
Analyst Bob Hopkins cited three things, including: 1) ABT's strong Q4 results yesterday, which suggest estimates have bottomed with strong revenue growth and margin expansion highly likely... More
